91AV

Introduction

Peptide therapeutics continue to expand across modalities and indications, yet their 91AV, Manufacturing and Controls (CMC) present distinctive challenges: complex synthesis routes, diverse impurity profiles (process-, product-, and degradation-related), and evolving regulatory expectations. This course, delivered by Scientific Update, provides a practical, end‑to‑end framework for developing and executing robust impurity management and control strategies for peptide drug substances and drug products. Through a combination of technical lectures, case studies, and interactive exercises, participants will learn how to design phase‑appropriate CMC strategies that accelerate development, reduce risk, and meet global regulatory requirements.

Useful links

Speakers

• Dr Osama Chahrour AstraZeneca, United Kingdom
• Dr Andy Teasdale ATCMC Consultant, United Kingdom

---

Organised by

Scientific Update offers specialised conferences and training courses for industrial chemists and chemical engineers.

Contact information

Events Team
Scientific Update Ltd
+44 1892 956222
Contact us by email

---